Clinical trial
HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related Disease
NCT00243724 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00243724 |
|---|---|
| Title | HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related Disease |
| Official title | An Open-Label, Parallel-Group, Multi-Centre Study to Determine the Effect of Treatment With Esomeprazole for Six Months on Histological Markers of Esophageal Epithelial Acid-Related Disease in Patients With Upper GI Symptoms. |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastroesophageal Reflux, Heartburn, Dyspepsia |
| Intervention type | Drug |
| Interventions | Esomeprazole |
| Enrollment | 350 |
| Start date | Apr 1, 2005 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Oct 25, 2005 |
| Last update posted | Mar 26, 2009 |
| Countries | Canada |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: